Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymorphic hydroxylation of perhexiline in vitro.

L B Sørensen1, R N Sørensen, J O Miners

  • 1Department of Clinical Pharmacology, Flinders Medical Centre and Flinders University of South Australia, Bedford Park, Australia.

British Journal of Clinical Pharmacology
|June 20, 2003
PubMed
Summary

Perhexiline monohydroxylation is primarily driven by CYP2D6, with significantly lower activity observed in CYP2D6 poor metabolizers. These findings predict the in vivo metabolism and pharmacogenetics of perhexiline.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and evaluation of a new semi-quantitative and morphometric scoring system for magnetic resonance imaging in adolescents with Osgood Schlatter Disease (The OSIS Score).

European journal of radiology·2025
Same author

Understanding the Interactions Between Loading, Pain Dynamics, and Imaging Characteristics for Osgood Schlatter: A Cross-Sectional Study.

Scandinavian journal of medicine & science in sports·2024
Same author

A comprehensive MRI investigation to identify potential biomarkers of Osgood Schlatter disease in adolescents: A cross sectional study comparing Osgood Schlatter disease with controls.

Scandinavian journal of medicine & science in sports·2024
Same author

Subgrouping of facilitatory or inhibitory conditioned pain modulation responses in patients with chronic knee pain. Explorative analysis from a multicentre trial.

European journal of pain (London, England)·2023
Same author

Factors associated with persistent opioid use 6-12 months after primary total knee arthroplasty.

Anaesthesia·2022
Same author

Persistent postoperative pain after total knee arthroplasty: a prospective cohort study of potential risk factors.

British journal of anaesthesia·2018

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Enzyme Kinetics

Background:

  • Perhexiline is an antianginal agent whose metabolism and pharmacogenetics are not fully understood.
  • Understanding the enzymes responsible for perhexiline metabolism is crucial for optimizing its therapeutic use and minimizing adverse effects.

Purpose of the Study:

  • To investigate the in vitro enzyme kinetics of perhexiline monohydroxylation.
  • To determine the specific Cytochrome P450 (CYP) isoforms involved in perhexiline metabolism using human liver microsomes.

Main Methods:

  • Human liver microsomes from 20 donors were used to assess perhexiline monohydroxylation rates.
  • High-performance liquid chromatography (HPLC) with precolumn derivatization was employed to quantify product formation.
  • CYP isoform selectivity was determined using isoform-selective inhibitors.

Related Experiment Videos

Main Results:

  • Perhexiline monohydroxylation rates varied 50-fold across the studied liver microsomes.
  • The apparent Km, Vmax, and intrinsic clearance were determined for extensive and poor metabolizers.
  • Quinidine, a CYP2D6 inhibitor, almost completely abolished perhexiline monohydroxylation, while other inhibitors had minimal impact.

Conclusions:

  • Perhexiline monohydroxylation is predominantly catalyzed by the CYP2D6 enzyme.
  • Activities were approximately 100-fold lower in CYP2D6 poor metabolizers compared to extensive metabolizers.
  • In vitro findings suggest saturable metabolism and predictable pharmacogenetics for perhexiline in vivo.